US Patent 8022221 Aurora kinase modulators and method of use
Patent 8022221 was granted and assigned to Amgen on September, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+93 characters)
Article
Patent abstract
The present invention relates to chemical compounds having a general formula I
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Bingfan Du0
Brian L. Hodous0
Hanh Nho Nguyen0
Holly L. Deak0
Karina Romero0
Laurie Schenkel0
Philip R. Olivieri0
Stephanie D. Geuns-Meyer0
Victor J. Cee0
Vinod F. Patel0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08022221 Aurora kinase modulators and method of use US Patent 8022221 Aurora kinase modulators and method of use
Infobox
Patent Number
080222210
Patent Number
80222210
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080222210
Date of Patent
September 20, 2011
0Patent Application Number
123784260
Date Filed
February 12, 2009
0Patent Primary Examiner
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08022221 Aurora kinase modulators and method of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08022221
Date of patent
September 20, 2011
Patent application number
12378426
Date Filed
February 12, 2009
Patent primary examiner
Find more entities like US Patent 8022221 Aurora kinase modulators and method of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
